A sensitive two-site enzyme immunoassay for human epidermal growth factor (urogastrone).
A sensitive enzyme immunoassay (EIA) was developed for human epidermal growth factor (hEGF) or urogastrone, which was isolated from human urine. Our EIA system is based on the sandwiching of an antigen between anti-hEGF IgG coated on a polystyrene tube and anti-hEGF antibody Fab'-linked beta-D-galactosidase (beta-D-galactosidase, EC 3.2.1.23). This method has the advantages that the procedures are simple and rapid and that the antibody Fab'-beta-D-galactosidase complex is more stable than radioisotope-labeled IgG. Purified hEGF is detectable at as low as 100 pg/ml, which is very sensitive compared to the radioimmuno-assays or radioreceptor assays already reported. Using this new EIA system, hEGF levels in human urine were examined. The values for normal males and females were 48.4 and 83.5 ng/mg creatinine, respectively, which shows that females excrete 1.7 times more hEGF than males.
D004591:Electrophoresis, Polyacrylamide Gel; D004815:Epidermal Growth Factor / Q000032:analysis* / Q000652:urine; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male
D004815:Epidermal Growth Factor